Browse Huntington's chorea topic

Care and treatment subtopic

Articles 1-31 out of 31 article(s) Title Author Type Date Words Neuron function to brains damaged by Huntington's disease restored. May 30, 2012 447 Researchers Restore Neuron Function to Brains Damaged by Huntington's Disease. May 29, 2012 569 'Very promising' treatment for Huntington disease discovered. Feb 14, 2012 360 Alnylam Announces Publication of Pre-clinical Results with ALN-HTT, an RNAi Therapeutic for the Treatment of Huntington's Disease, in Experimental Neurology. Financial report Dec 28, 2011 1495 Key protein behind Huntington's disease identified. Oct 31, 2011 178 Biomarker gene target identified to track Huntington's disease. Oct 4, 2011 243 Promoting excellence in end-of-life care: lessons learned from a cohort of nursing home residents with advanced Huntington disease. Dellefield, Mary E.; Ferrini, Rebecca Aug 1, 2011 4534 Don't forget about the end. Nance, Martha A. Disease/Disorder overview Mar 22, 2011 756 Huntington's disease. Brief article Jan 1, 2011 207 Long-term effects of olanzapine in various movement disorders/ Cesitli hareket bozukluklarinda olanzapin'in uzun sureli etkileri. Coban, Arzu; Hanagasi, Hasmet A. Clinical report Sep 1, 2010 2178 Repligen Receives Additional Research Grants to Support Development of HDAC Inhibitors for Friedreich's Ataxia and Huntington's Disease. Aug 2, 2010 1418 Ripples from a stone skipping across the lake: a narrative approach to the meaning of Huntington's disease. Schwartz, Rose Rossi Jun 1, 2010 8819 Hypnosis and the Treatment of Huntington's Disease. Hartman, David Report Mar 22, 2010 131 Coenzyme Q10 and creatine combination produces additive neuroprotective effects in models of Parkinson's and Huntington's diseases. Finkel, Jon Brief article Mar 1, 2010 149 A 27-year-old hay fever treatment being studied by Pfizer Inc (New York) and Medivation Inc (San Francisco CA) for Alzheimer's disease may also help patients with Huntington's disease. Feb 15, 2010 348 Pfizer And Medivation Initiate Phase 3 Trial Of Dimebon In Patients With Huntington Disease. Jul 30, 2009 1092 Cambridge Laboratories Announces Launch of XENAZINE(R) (Tetrabenazine) in the US. Dec 1, 2008 778 Alnylam and Collaborators Publish New Pre-clinical Results on RNAi Therapeutics for the Treatment of Huntington's Disease. Oct 17, 2007 1007 Successful neuropharmacologic therapy of Huntington's disease: a case report. Lechin, Fuad; Hernandez-Adrian, Gerardo; van der Dijs, Bertha Clinical report Jun 1, 2007 1984 Proteome Systems and HighQ Foundation Announce the Discovery of Prognostic and Diagnostic Markers for Neurodegenerative Disease; Two-Year Human Study Launched to Validate Markers and Enable Rapid Drug Development. Jan 12, 2006 806 Alnylam Announces Progress in Pre-clinical Programs at the 35th Annual Society for Neuroscience Meeting; Pre-clinical Data from Parkinson's Disease, Huntington's Disease, and Neuropathic Pain Programs. Nov 15, 2005 1007 Delaying Huntington's diagnosis may lead to increased risk of suicide. Sullivan, Michele G. Brief article Oct 1, 2005 268 Sirna granted patent covering siRNAs targeting Huntington's Disease. Sep 1, 2005 1128 Diagnosis of Huntington disease. Margolis, Russell L.; Ross, Christopher A. Oct 1, 2003 4609 Clinical trial update. Brief Article Jun 1, 2003 251 Remotivation Therapy and Huntington's Disease. Sullivan, Florinda R.; Bird, Edward D.; Alpay, Menekse; Cha, Jang-Ho J. Jun 1, 2001 5502 Understanding the Neuropsychiatric Symptoms of Huntington's Disease. Hofmann, Nancy Oct 1, 1999 3475 Fetal cells tried for Huntington's. Travis, John Brief Article Dec 21, 1996 346 Catholic and antiabortion, he needs fetal tissue operation. Bavley, Alan Cover Story Nov 8, 1996 1064 Fetal tissue: a hope for Huntington's? Ezzell, Carol Nov 16, 1991 669 Experimental cell grafts for Huntington's. Apr 23, 1988 222